TOVIAZ

This brand name is authorized in Austria, Canada, Cyprus, Germany, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, Poland, Turkey, United Kingdom, United States

Active ingredients

The drug TOVIAZ contains one active pharmaceutical ingredient (API):

1 Fesoterodine UNII EOS72165S7 - FESOTERODINE FUMARATE

Fesoterodine is a competitive, specific muscarinic receptor antagonist. It is rapidly and extensively hydrolysed by non-specific plasma esterases to the 5-hydroxymethyl derivative, its primary active metabolite, which is the main active pharmacological principle of fesoterodine. Read about Fesoterodine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TOVIAZ Prolonged-release tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G04BD11	Fesoterodine	G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BD Urinary antispasmodics
Discover more medicines within G04BD11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02380021, 02380048
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00020511, 00020540, 00568640, 00571808, 05450624, 05450653, 05892339, 05892397, 06130560, 06562271, 06575380, 06575397, 08844074, 08844097, 09196157, 09442509, 10796336, 10796342, 11227296, 13892483, 13892750, 14046187
Country: EE	Ravimiamet	Identifier(s): 1294534, 1294545, 1294556, 1294567, 1294578, 1294589, 1294590, 1294602, 1294613, 1294624, 1462553, 1462564, 1462575, 1462586, 1462597, 1462609, 1462610, 1462621
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 07386003, 07386008, 07386008IP, 07386008IP1, 07386008IP2
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 116694, 116705, 116716, 116727
Country: FR	Base de données publique des médicaments	Identifier(s): 66259498, 68479557
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 136181, 136184, 196212, 375514, 381392
Country: IE	Health Products Regulatory Authority	Identifier(s): 13215, 13216, 47505, 47506, 47526, 47527, 47553, 47575
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6261, 6262
Country: IT	Agenzia del Farmaco	Identifier(s): 038699017, 038699029, 038699031, 038699043, 038699056, 038699068, 038699070, 038699082, 038699094, 038699106, 038699118, 038699120, 038699132, 038699144, 038699157, 038699169, 038699171, 038699183, 038699195, 038699207
Country: JP	医薬品医療機器総合機構	Identifier(s): 2590015G1021, 2590015G2028
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1031299, 1031300, 1031301, 1031302, 1031303, 1031304, 1031305, 1031306, 1031307, 1031308, 1036072, 1036073, 1036074, 1036075, 1036076, 1036077, 1054667, 1054668, 1068266, 1068267
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 86258, 86266
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100180980, 100180996
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8681308030511, 8681308035127, 8681308035141, 8681308035790, 8681308035806, 8681308039514
Country: US	FDA, National Drug Code	Identifier(s): 0069-0242, 0069-0244, 55154-2737, 55154-2738, 63539-183, 63539-242